Rolipram is a selective phosphodiesterase-4 inhibitor investigated primarily for its potential therapeutic effects in treating neurodegenerative conditions such as Alzheimer’s disease. By elevating intracellular… Read more
Rolipram is a selective phosphodiesterase-4 inhibitor investigated primarily for its potential therapeutic effects in treating neurodegenerative conditions such as Alzheimer’s disease. By elevating intracellular cyclic AMP levels, this compound modulates neuronal signaling pathways to support cognitive function. The reference standards for Rolipram and its associated compounds listed here are essential for rigorous analytical testing and quality control within pharmaceutical laboratories. This category provides access to the active pharmaceutical ingredient, its chiral enantiomers, and related impurities or stable isotope labelled analogues, which are critical for accurate impurity profiling and method validation. Researchers and analysts utilize these high-quality reference materials to ensure the precision of stability-indicating assays and the consistent characterization of drug batches throughout the development lifecycle, supporting the maintenance of stringent regulatory standards for both research and industrial applications.